Protease inhibitor use among a community sample of people with HIV disease

被引:39
作者
Bing, EG
Kilbourne, AM
Brooks, RA
Lazarus, EF
Senak, M
机构
[1] Charles R Drew Univ Med & Sci, Dept Psychiat, Los Angeles, CA 90059 USA
[2] Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Serv, Los Angeles, CA 90024 USA
[3] AIDS Project Los Angeles, Los Angeles, CA USA
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 1999年 / 20卷 / 05期
关键词
HIV; protease inhibitors; antiviral agents; health care utilization;
D O I
10.1097/00042560-199904150-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: Protease inhibitors have become integral to HIV disease management. This paper examines sociodemographic factors affecting patient use and perceived knowledge of protease inhibitors, and the relationship between protease inhibitor use and perceived health. Methods: 1034 people with HIV disease from a large AIDS services organization completed a mailed self-administered survey that assessed sociodemographics, protease inhibitor use and perceived knowledge, and perceived change in health status over the previous year. Multiple logistic regression was used to determine sociodemographic factors independently associated with protease inhibitor use and perceived knowledge, and perceived overall health status. Results: Two thirds (66%) of correspondents included in the sample were currently taking protease inhibitors and 52% reported being very knowledgeable about these medications. Adjusting for sociodemographic factors, those who were currently not taking protease inhibitors were more likely to be African American, non-English speaking, earning <$9600 U.S. annually, or uninsured. Among protease inhibitor users, those who reported less knowledge about the drugs were more likely to be nonwhite, earning <$9600 U.S. annually, and not college educated. Protease inhibitor use was independently associated with perceived improved overall health and having been college educated. Conclusions: Further efforts should be directed toward increasing use and knowledge of protease inhibitors among disadvantaged populations.
引用
收藏
页码:474 / 480
页数:7
相关论文
共 38 条
[1]  
Batey RG, 1997, ADDICTION, V92, P1189
[2]  
BING EG, 1998, RCMI INT AIDS S PU R
[3]  
Boswell E B, 1996, Am J Med, V101, p3S, DOI 10.1016/S0002-9343(96)00392-0
[4]   The study of untreated syphilis in the Negro male [J].
Brawley, OW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (01) :5-8
[5]  
Bright P E, 1996, Ethn Health, V1, P77
[6]   Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24) :1962-1969
[7]   Antiretroviral therapy for HIV infection in 1996 - Recommendations of an international panel [J].
Carpenter, CCJ ;
Fischl, MA ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schooley, RT ;
Thompson, MA ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :146-154
[8]   Self-reported antiretroviral therapy in injection drug users [J].
Celentano, DD ;
Vlahov, D ;
Cohn, S ;
Shadle, VM ;
Obasanjo, O ;
Moore, RD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (06) :544-546
[9]  
Center for Educational Research and Innovation, 1998, HUM CAP INV INT COMP, P9
[10]  
Chavkin W, 1997, ADDICTION, V92, P1201